Reviewers

Authors

1 Department of Biology, Faculty of Basic Science, Islamic Azad University, East-Tehran Branch, Tehran, Iran.

2 Department of Health, Safety and Environment (HSE), Faculty of Health Science, Pars Petrochemical Company, South Pars Special Economic Zone, Asaluyeh, Iran.

10.22034/atj.2024.195108

Abstract

Autoimmune disorders are complex conditions that result from a combination of genetic and
environmental causes and currently have no recognized therapy. Various therapeutic strategies
may be used in various illnesses to promote remission or, at the very least, alleviate the symptoms.
For customized therapy to be implemented, it is necessary to identify groups of individuals who are
generally similar and share pathogenic signaling pathways. Therefore, research about autoimmune
disorders mainly focuses on identifying new biomarkers, uncovering novel targets for therapy and
agents, and understanding the processes involved in developing various disorders. We are just at the
nascent phase of implementing tailored therapy for autoimmune illnesses. Hence, this research delved
into the examination of several autoimmune illnesses and the impact of personalized therapy on their
progression.

Keywords